From sporadic outbreaks of Aedes-borne dengue and chikungunya, the European Union is transitioning towards an endemic state, ...

The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...

The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...

Climate change is pushing disease-carrying tiger mosquitoes deeper into Europe, raising the risk that once-tropical viruses ...

Early COVID suppression could have prevented 180,000 UK deaths, study reveals … FDA, CDC pause chikungunya vaccine for adults ...

A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...